Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Long non-coding RNAs (lncRNAs) have been proved to serve as a critical role in cancer development and progression. However, little is known about the pathological role of lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in pancreatic cancer patients. The aims of this study are to measure the expression of lncRNA MALAT1 in pancreatic cancer patients and to explore the clinical significance of the lncRNA MALAT1. Using qRT-PCR, the expression of lncRNA MALAT1 was measured in 126 pancreatic cancer tissues and 15 adjacent non-cancerous tissues. In the present study, our results indicated that lncRNA MALAT1 was highly expressed in pancreatic cancer compared with adjacent non-cancerous tissues (P < 0.001), and positively correlated with clinical stage (early stages vs. advanced stages, P < 0.001), tumor size (<2 vs. ≥2 cm, P = 0.004), lymph node metastasis (negative vs. positive, P < 0.001), and distant metastasis (absent vs. present, P = 0.001) in pancreatic cancer patients. Furthermore, we also found that lncRNA MALAT1 overexpression was an unfavorable prognostic factor in pancreatic cancer patients (P < 0.001), regardless of clinical stage, tumor size, lymph node metastasis, and distant metastasis. Finally, increased lncRNA MALAT1 expression was an independent poor prognostic factor for pancreatic patients through multivariate analysis (P = 0.018). In conclusion, overexpression of lncRNA MALAT1 serves as an unfavorable prognostic biomarker in pancreatic cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.21208.

    Google Scholar 

  2. Guo X, Cui Z. Current diagnosis and treatment of pancreatic cancer in China. Pancreas. 2005;31(1):13–22.

    Article  CAS  PubMed  Google Scholar 

  3. Chen Y, Hao J, Ma W, Tang Y, Gao C, Hao X. Improvement in treatment and outcome of pancreatic ductal adenocarcinoma in north China. J Gastrointest Surg: Off J Soc Surg Aliment Tract. 2011;15(6):1026–34. doi:10.1007/s11605-011-1493-y.

    Article  Google Scholar 

  4. Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010;7(3):163–72. doi:10.1038/nrclinonc.2009.236.

    Article  CAS  PubMed  Google Scholar 

  5. Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990–2010. World J Gastroenterol: WJG. 2011;17(7):867–97. doi:10.3748/wjg.v17.i7.867.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–109. doi:10.1016/j.bbagrm.2014.08.012.

    Article  CAS  PubMed  Google Scholar 

  7. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009;5(4):e1000459. doi:10.1371/journal.pgen.1000459.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, et al. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer. 2011;10:141. doi:10.1186/1476-4598-10-141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sun YW, Chen YF, Li J, Huo YM, Liu DJ, Hua R, et al. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1alpha in pancreatic ductal adenocarcinoma. Br J Cancer. 2014. doi:10.1038/bjc.2014.520.

    Google Scholar 

  10. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7′s suppression on its target HMGA2-mediated EMT. Tumour Biol: J Int Soc Oncodev Biol Med. 2014;35(9):9163–9. doi:10.1007/s13277-014-2185-5.

    Article  CAS  Google Scholar 

  11. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32(13):1616–25. doi:10.1038/onc.2012.193.

    Article  CAS  PubMed  Google Scholar 

  12. Gutschner T, Hammerle M, Diederichs S. MALAT1—a paradigm for long noncoding RNA function in cancer. J Mol Med (Berlin, Germany). 2013;91(7):791–801. doi:10.1007/s00109-013-1028-y.

    Article  CAS  Google Scholar 

  13. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031–41. doi:10.1038/sj.onc.1206928.

    Article  PubMed  Google Scholar 

  14. Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D, et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer. 2011;6(12):1984–92. doi:10.1097/JTO.0b013e3182307eac.

    Article  Google Scholar 

  15. Han Y, Liu Y, Nie L, Gui Y, Cai Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology. 2013;81(1):209 e201–207. doi:10.1016/j.urology.2012.08.044.

    Article  Google Scholar 

  16. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol BioSyst. 2012;8(9):2289–94. doi:10.1039/c2mb25070e.

    Article  CAS  PubMed  Google Scholar 

  17. Lin R, Maeda S, Liu C, Karin M, Edgington TS. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene. 2007;26(6):851–8. doi:10.1038/sj.onc.1209846.

    Article  CAS  PubMed  Google Scholar 

  18. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology (Baltim, Md). 2006;44(4):1012–24. doi:10.1002/hep.21328.

    Article  CAS  Google Scholar 

  19. Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A. Prognostic significance of drug-regulated genes in high-grade osteosarcoma. Mod Pathol: Off J U S Can Acad Pathol Inc. 2007;20(10):1085–94. doi:10.1038/modpathol.3800937.

    Article  CAS  Google Scholar 

  20. Jiao F, Hu H, Yuan C, Wang L, Jiang W, Jin Z, et al. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer. Oncol Rep. 2014;32(6):2485–92. doi:10.3892/or.2014.3518.

    CAS  PubMed  Google Scholar 

  21. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res: Off J Am Assoc Cancer Res. 2008;14(8):2334–40. doi:10.1158/1078-0432.ccr-07-4667.

    Article  CAS  Google Scholar 

  22. Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3):651–69. doi:10.1534/genetics.112.146704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45(11):604–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Liu JH, Chen G, Dang YW, Li CJ, Luo DZ. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pac J Cancer Prev: APJCP. 2014;15(7):2971–7.

    Article  PubMed  Google Scholar 

  25. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol (Northwood, London, England). 2012;29(3):1810–6. doi:10.1007/s12032-011-0004-z.

    Article  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Surgery, The Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, 200233, China

    Er-Jun Pang

  2. Department of General Surgery, The Fifth Hospital of Wuhan, Wuhan, 430050, China

    Rui Yang

  3. Department of Hepatobiliary Surgery, Liaoning Cancer Hospital & Institute, Dalian Medical University Clinical Oncology College, Dalian, 110042, Liaoning, China

    Xi-bo Fu & Ye-fu Liu

Authors
  1. Er-Jun Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xi-bo Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ye-fu Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ye-fu Liu.

Additional information

Er-Jun Pang and Rui Yang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pang, EJ., Yang, R., Fu, Xb. et al. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumor Biol. 36, 2403–2407 (2015). https://doi.org/10.1007/s13277-014-2850-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2850-8

Keywords

Search

Navigation